5-Year Safety and Efficacy of Resolute Zotarolimus-Eluting Stent
- 1 February 2017
- journal article
- Published by Elsevier BV in JACC: Cardiovascular Interventions
- Vol. 10 (3), 247-254
- https://doi.org/10.1016/j.jcin.2016.11.004
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Coronary stents: historical development, current status and future directionsBritish Medical Bulletin, 2013
- Assessing the Temporal Course of Neointimal Hyperplasia Formation After Different Generations of Drug-Eluting StentsJACC: Cardiovascular Interventions, 2011
- Five-Year Clinical and Angiographic Outcomes of a Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting StentsCirculation, 2011
- The Pathology of Neoatherosclerosis in Human Coronary ImplantsJournal of the American College of Cardiology, 2011
- 5-Year Follow-Up After Primary Percutaneous Coronary Intervention With a Paclitaxel-Eluting Stent Versus a Bare-Metal Stent in Acute ST-Segment Elevation Myocardial Infarction: A Follow-Up Study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction With ST-Segment Elevation) TrialJACC: Cardiovascular Interventions, 2011
- Stent Thrombosis in SwedenCirculation: Cardiovascular Interventions, 2009
- Pathological Correlates of Late Drug-Eluting Stent ThrombosisCirculation, 2007
- Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary StentsNew England Journal of Medicine, 2007
- Pathology of Drug-Eluting Stents in HumansJournal of the American College of Cardiology, 2006
- Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting StentCirculation, 2004